Thoracoscopic Lobectomy for Thoracic Surgery

McMaster University / St. Joseph's Healthcare Hamilton, Hamilton, Canada
Thoracic Surgery+1 More ConditionsRobotic thoracic surgery - Procedure
All Sexes

Study Summary

This trial will help determine if robotic technology is better than traditional methods for early stage lung cancer surgery.

Eligible Conditions
  • Thoracic Surgery
  • Non-Small Cell Lung Cancer

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3

Study Objectives

1 Primary · 5 Secondary · Reporting Duration: 5 years post-surgery

1 year post-surgery
Resource utilization
12 weeks post-surgery
Difference in HRQOL scores at week 12 between the treatment groups
3 weeks post-surgery
Short-term clinical outcome differences
Year 5
Difference in HRQOL scores between the treatment groups
5 years post-surgery
Cost Effectiveness
Difference in 5-year survival rate between the two groups

Trial Safety

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

2 Treatment Groups

Thoracoscopic Lobectomy
1 of 2
Robotic Lobectomy
1 of 2

Active Control

592 Total Participants · 2 Treatment Groups

Primary Treatment: Thoracoscopic Lobectomy · No Placebo Group · N/A

Thoracoscopic Lobectomy
ActiveComparator Group · 1 Intervention: Video-assisted thoracoscopic surgery · Intervention Types: Procedure
Robotic Lobectomy
ActiveComparator Group · 1 Intervention: Robotic thoracic surgery · Intervention Types: Procedure

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 5 years post-surgery

Who is running the clinical trial?

University of Toronto / Toronto General HospitalUNKNOWN
University of FloridaOTHER
1,274 Previous Clinical Trials
699,574 Total Patients Enrolled
Rouen Normandy University / CHU-Hopitaux de Rouen (Rouen, France)UNKNOWN
St Vincent's Hospital MelbourneOTHER
27 Previous Clinical Trials
6,684 Total Patients Enrolled
University of Melbourne / St. Vincent's Private Hospital (Fitzroy, Australia)UNKNOWN
University of Melbourne / Barwon Health (Geelong, Australia)UNKNOWN
St. Joseph's Healthcare HamiltonLead Sponsor
187 Previous Clinical Trials
24,953 Total Patients Enrolled
1 Trials studying Thoracic Surgery
Waël C Hanna, MDCM, MBA, FRCSCPrincipal InvestigatorMcMaster University
3 Previous Clinical Trials
150 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 2 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have early-stage non-small cell lung cancer that has not spread too far.
The surgeon has determined that you are a suitable candidate for minimally invasive surgery to remove a part of your lung.

Frequently Asked Questions

Is enrollment for this experiment still open?

"According to records published on, this experiment is still recruiting patients. The initial post was made in January 2016 and the trial was recently updated in November 2022." - Anonymous Online Contributor

Unverified Answer

How many participants are being recruited for this medical experiment?

"Indeed, indicates that this trial is actively recruiting participants. It was first listed on January 1st 2016 and the most recent update occurred on November 2nd 2022. The study requires a total of 592 patients from one facility to be enrolled in order to commence its research agenda." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.